In Vitro activities of tigecycline (GAR-936) and 12 other antimicrobial agents against 90 Eikenella corrodens clinical isolates

被引：12
|
作者：
Cercenado, E [1 ]
Cercenado, S [1 ]
Bouza, E [1 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Microbiol Serv, Madrid 28007, Spain
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2003年 / 47卷 / 08期
关键词：
D O I：
10.1128/AAC.47.8.2644-2645.2003
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The activity of tigecycline was compared with those of other antimicrobials against 90 isolates of Eikenella corrodens. The MIC at which 90% of the isolates were inhibited was 2 mug/ml for tigecycline and 1, less than or equal to0.5/0.25, 0.5, less than or equal to0.12, less than or equal to2, and 0.5 mug/ml for ampicillin, amoxicillin-clavulanate, cefotaxime, imipenem, chloramphenicol, and ciprofloxacin, respectively.
引用
收藏
页码：2644 / 2645
页数：2
相关论文
共 50 条
  • [1] Comparative in vitro activities of tigecycline (GAR-936) and other antimicrobial agents against Stenotrophomonas maltophilia
    Betriu, C
    Rodríguez-Avial, I
    Sánchez, BA
    Gómez, M
    Picazo, JJ
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (05) : 758 - 759
  • [2] In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain
    Betriu, C
    Rodríguez-Avial, I
    Sánchez, BA
    Gómez, M
    Alvarez, J
    Picazo, JJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) : 892 - 895
  • [3] Activity of GAR-936 and other antimicrobial agents against North American isolates of Staphylococcus aureus
    Low, DE
    Kreiswirth, BN
    Weiss, K
    Willey, BM
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (03) : 220 - 222
  • [4] In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates
    Rodriguez-Avial, Iciar
    Rodriguez-Avial, Carmen
    Lopez, Olga
    Culebras, Esther
    Picazo, Juan J.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 27 (04) : 303 - 306
  • [5] Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936)
    Henwood, CJ
    Gatward, T
    Warner, M
    James, D
    Stockdale, MW
    Spence, RP
    Towner, KJ
    Livermore, DM
    Woodford, N
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (03) : 479 - 487
  • [6] Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates
    Milatovic, D
    Schmitz, FJ
    Verhoef, J
    Fluit, AC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) : 400 - 404
  • [7] In vitro activities of tigecycline (GAR-936) against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae
    Kitzis, MD
    Ly, A
    Goldstein, FW
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) : 366 - 367
  • [8] In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens
    Petersen, PJ
    Bradford, PA
    Weiss, WJ
    Murphy, TM
    Sum, PE
    Projan, SJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) : 2595 - 2601
  • [9] Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L-pneumophila pneumonia
    Edelstein, PH
    Weiss, WJ
    Edelstein, MAC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) : 533 - 540
  • [10] In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria
    Boucher, HW
    Wennersten, CB
    Eliopoulos, GM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) : 2225 - 2229
12345